Filter

581 - 590 of 592 Results

  • International Assistance for HIV/AIDS in the Developing World: Taking Stock of the G8, Other Donor Governments and The European Commission, 2005

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2005, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

  • Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission, 2004

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2004, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

  • Donor Government Funding for HIV in Low- and Middle-Income Countries in 2024

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2024, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

  • Donor Government Funding for Global Family Planning Declines to Lowest Level Since 2016

    News Release

    A new KFF analysis finds donor government funding for family planning efforts in low- and middle-income countries totaled US$1.35 billion in 2022, a decline of 9% (US$129 million) compared to 2021 ($1.48 billion). This figure marks the lowest level of funding since 2016 ($1.31 billion). While some of the decline was because of decreases in actual funding by most donor governments, more than two-thirds can be attributed to exchange rate fluctuations due to the strengthening…

  • House Committee on Appropriations Releases FY 2024 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report

    Fact Sheet

    The House Committee on Appropriations released its FY 2024 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill on July 13, 2023 and accompanying report on November 3, 2023. The Labor HHS appropriations bill includes funding for U.S. global health programs provided to the Centers for Disease Control and Prevention (CDC) and funding for global health research activities provided to the National Institutes of Health (NIH). Total global health funding at…

  • Medicare 101

    Feature

    This Health Policy 101 chapter explores Medicare, a federal health insurance program covering more than 68 million people, established in 1965 for people age 65 or older and later expanded to cover people under age 65 with long-term disabilities. In addition to detailing Medicare eligibility, coverage, and spending, the chapter examines the increased role of private plans in providing benefits and the financing challenges posed by increasing health care costs and an aging population.

  • Medicaid: What to Watch in 2024

    Issue Brief

    As the start of 2024, many issues are at play that will affect Medicaid coverage, financing, and access. This issue brief provides context for these Medicaid issues and highlights key issues to watch in the year ahead.

  • Global Health Funding in the FY 2024 Final Appropriations Bill

    Fact Sheet

    Updated: March 25, 2024 On March 23, 2024, the President signed the second package of final FY 2024 appropriations bills, otherwise known as the “Further Consolidated Appropriations Act, 2024,” which was released by the House and Senate Appropriations Committees on March 20, 2024, passed by the House on March 22, 2024 and passed by the Senate on March 23, 2024. The bill includes funding for U.S. global health programs at the State Department, U.S. Agency…

  • Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss

    News Release

    A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes. This week the Centers for Medicare & Medicaid Services (CMS) informed Medicare drug plans that they can cover Wegovy, another…